Event Overview
Laboratory Information Management Systems (LIMS) have advanced significantly beyond basic sample tracking. In modern pharmaceutical and biotech settings, LIMS must not only maintain data integrity but also serve as the core of laboratory automation and a vital element of broader manufacturing systems. They support compliance with ALCOA+ principles and facilitate integration with ERP, MES, and QMS systems, ensuring both laboratory accuracy and enterprise data connectivity.
This Expert Forum brings together industry professionals to exchange practical insights, experiences, and lessons learned on implementing and optimising LIMS — highlighting their role as guardians of data integrity and fundamental components of the digital manufacturing landscape.
LIMS as Part of the Manufacturing Application Landscape
The presentations and panel discussions expands the scope from the laboratory to the full manufacturing context. It highlights how LIMS interact with enterprise systems to ensure seamless data flows, efficient operations, and robust quality management.
Objective:
To position LIMS within the broader manufacturing IT ecosystem, showing its role as a central link between laboratory, production, and enterprise systems.
Topics:
- LIMS/ELN as the backbone of laboratory automation in Development and QC
- Integration with the supply chain via ERP: monitoring incoming goods, intermediates, and finished products
- Raw data management and long-term archiving
- LIMS and QMS: SOP management, change control, and complaints handling
- Interfaces with Manufacturing Execution Systems (MES), Process Control Systems (PCS), and sensors
- Time-based data sources and historians for process monitoring
- Enterprise management information: linking pilot batches, manufacturing, and development
- Data warehouses for KPI tracking and management insights
- ISO 95 levels and the role of LIMS in the layered application landscape
What you need to know:
Dual-time broadcast, with starting times as follows:
Wednesday, 26 January 2026
- Broadcast #1 (Europe / Asia): 09:00 h GMT (London) / 10:00 h CET (Paris/Berlin) / 14:30 h IST (New Delhi) / 17:00 h SGT (Singapore) / 18:00 h JST (Tokyo)
- Broadcast #2 (North America / Europe): 08:00 h PST (Los Angeles) / 11:00 h EST (New York) / 16:00 h GMT (London) / 17:00 h CET (Paris/Berlin)
Duration: Approximately 60 – 90 minutes, incl. Q&A.
- Registrants attending this online event’s live broadcast sessions will receive a ‘Certificate of Attendance’.
- If you’re unable to join the live broadcast, register anyway, and we’ll send you the recording.
- Join the BioQC user community for ongoing discussions after the event.
Who should attend?
- Quality Control (QC) professionals, Quality Assurance (QA), Information Technology (IT) and Computerised System Validation (CSV) specialists, laboratory managers, and regulatory affairs experts
Related event
Register now: Beyond Sample Tracking – LIMS as the Backbone of Laboratory Data Integrity
This expert forum focuses on the evolution of LIMS from paper-based tracking tools to full-fledged data management systems. It explores how LIMS ensure compliance, reduce human error through automation, and support trustworthy, audit-ready laboratory data.
Presenters / Panellists
Paul Schrevel
LIMS Implementation Manager and CSV/GAMP 5 specialist
Solution Too (The Netherlands)
Jon Walker
Services Director
LabWare North America (USA)
Gloria Slomczynski, MBA
Laboratory Informatics and Management Consultant
(USA)
Moderators
Prof. Dr. Cari Sänger-van de Griend
Expert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.
Dr. Ewoud van Tricht
Expert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.






